Cargando…

Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach

The interaction of oncogenes with cellular proteins is a major determinant of cellular transformation. The NUP98-HOXA9 and SET-NUP214 chimeras result from recurrent chromosomal translocations in acute leukemia. Functionally, the two fusion proteins inhibit nuclear export and interact with epigenetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes, Adélia, Jühlen, Ramona, Bousbata, Sabrina, Fahrenkrog, Birthe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407662/
https://www.ncbi.nlm.nih.gov/pubmed/32664447
http://dx.doi.org/10.3390/cells9071666
_version_ 1783567673174523904
author Mendes, Adélia
Jühlen, Ramona
Bousbata, Sabrina
Fahrenkrog, Birthe
author_facet Mendes, Adélia
Jühlen, Ramona
Bousbata, Sabrina
Fahrenkrog, Birthe
author_sort Mendes, Adélia
collection PubMed
description The interaction of oncogenes with cellular proteins is a major determinant of cellular transformation. The NUP98-HOXA9 and SET-NUP214 chimeras result from recurrent chromosomal translocations in acute leukemia. Functionally, the two fusion proteins inhibit nuclear export and interact with epigenetic regulators. The full interactome of NUP98-HOXA9 and SET-NUP214 is currently unknown. We used proximity-dependent biotin identification (BioID) to study the landscape of the NUP98-HOXA9 and SET-NUP214 environments. Our results suggest that both fusion proteins interact with major regulators of RNA processing, with translation-associated proteins, and that both chimeras perturb the transcriptional program of the tumor suppressor p53. Other cellular processes appear to be distinctively affected by the particular fusion protein. NUP98-HOXA9 likely perturbs Wnt, MAPK, and estrogen receptor (ER) signaling pathways, as well as the cytoskeleton, the latter likely due to its interaction with the nuclear export receptor CRM1. Conversely, mitochondrial proteins and metabolic regulators are significantly overrepresented in the SET-NUP214 proximal interactome. Our study provides new clues on the mechanistic actions of nucleoporin fusion proteins and might be of particular relevance in the search for new druggable targets for the treatment of nucleoporin-related leukemia.
format Online
Article
Text
id pubmed-7407662
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74076622020-08-12 Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach Mendes, Adélia Jühlen, Ramona Bousbata, Sabrina Fahrenkrog, Birthe Cells Article The interaction of oncogenes with cellular proteins is a major determinant of cellular transformation. The NUP98-HOXA9 and SET-NUP214 chimeras result from recurrent chromosomal translocations in acute leukemia. Functionally, the two fusion proteins inhibit nuclear export and interact with epigenetic regulators. The full interactome of NUP98-HOXA9 and SET-NUP214 is currently unknown. We used proximity-dependent biotin identification (BioID) to study the landscape of the NUP98-HOXA9 and SET-NUP214 environments. Our results suggest that both fusion proteins interact with major regulators of RNA processing, with translation-associated proteins, and that both chimeras perturb the transcriptional program of the tumor suppressor p53. Other cellular processes appear to be distinctively affected by the particular fusion protein. NUP98-HOXA9 likely perturbs Wnt, MAPK, and estrogen receptor (ER) signaling pathways, as well as the cytoskeleton, the latter likely due to its interaction with the nuclear export receptor CRM1. Conversely, mitochondrial proteins and metabolic regulators are significantly overrepresented in the SET-NUP214 proximal interactome. Our study provides new clues on the mechanistic actions of nucleoporin fusion proteins and might be of particular relevance in the search for new druggable targets for the treatment of nucleoporin-related leukemia. MDPI 2020-07-10 /pmc/articles/PMC7407662/ /pubmed/32664447 http://dx.doi.org/10.3390/cells9071666 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mendes, Adélia
Jühlen, Ramona
Bousbata, Sabrina
Fahrenkrog, Birthe
Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach
title Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach
title_full Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach
title_fullStr Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach
title_full_unstemmed Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach
title_short Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach
title_sort disclosing the interactome of leukemogenic nup98-hoxa9 and set-nup214 fusion proteins using a proteomic approach
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407662/
https://www.ncbi.nlm.nih.gov/pubmed/32664447
http://dx.doi.org/10.3390/cells9071666
work_keys_str_mv AT mendesadelia disclosingtheinteractomeofleukemogenicnup98hoxa9andsetnup214fusionproteinsusingaproteomicapproach
AT juhlenramona disclosingtheinteractomeofleukemogenicnup98hoxa9andsetnup214fusionproteinsusingaproteomicapproach
AT bousbatasabrina disclosingtheinteractomeofleukemogenicnup98hoxa9andsetnup214fusionproteinsusingaproteomicapproach
AT fahrenkrogbirthe disclosingtheinteractomeofleukemogenicnup98hoxa9andsetnup214fusionproteinsusingaproteomicapproach